Skip to main content
logo
Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
388.64
-1.70 (-0.44%)
At close: Aug 26, 2026, 4:00 PM EDT
388.64
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:10 PM EDT

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
999.40M1.02B1.04B
EMEA Revenue
900.80M881.80M834.10M
APAC Revenue
515.00M513.30M521.60M
Other Regional Revenue
174.10M165.40M169.30M
Revenue (Total)
2.59B2.58B2.57B

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Life Science Revenue
1.01B1.02B1.03B
Clinical Diagnostics Revenue
1.58B1.56B1.54B
Other Segments Revenue
--500.00K
Revenue (Total)
2.59B2.58B2.57B

Gross Profit

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Life Science Segment Profit
547.50M553.10M582.40M
Clinical Diagnostics Segment Profit
796.30M786.80M796.60M
Other Segments Segment Profit
---100.00K
Gross Profit (Total)
1.34B1.34B1.38B